60 research outputs found
A note on the evaluation of a beta-casein variant in bovine breeds by allele-specific PCR and relevance to β-casomorphin
peer-reviewedThis work was supported by Enterprise Ireland and by a Teagasc Walsh fellowship to A.F. Keating.Two genetic variants of the bovine β-casein gene (A1 and B) encode a histidine residue at codon 67, resulting in potential liberation of a bioactive peptide, β-casomorphin, upon digestion. An allele-specific PCR (AS-PCR) was evaluated to distinguish between the β-casomorphin-releasing variants (A1 and B) and the non-releasing variants. AS-PCR successfully distinguished β-casein variants in 41 of 42 animals as confirmed by sequence analysis. Overall, while the incidence of the homozygous A1 and B animals (i.e., homozygous for the histidine residue; 21.4%) was lower than that for animals without the histidine residue (30.9% respectively), 69% of animals carried at least one allele for the histidine residue at codon 67.Teagasc Walsh Fellowship ProgrammeEnterprise Irelan
Simulação do risco de deficit hídrico em regiões de expansão do cultivo de cana-de-açúcar no Brasil
Broadband multi-wavelength properties of M87 during the 2017 Event Horizon Telescope campaign
In 2017, the Event Horizon Telescope (EHT) Collaboration succeeded in capturing the first direct image of the
center of the M87 galaxy. The asymmetric ring morphology and size are consistent with theoretical expectations
for a weakly accreting supermassive black hole of mass ∼6.5 × 109Me. The EHTC also partnered with several
international facilities in space and on the ground, to arrange an extensive, quasi-simultaneous multi-wavelength
campaign. This Letter presents the results and analysis of this campaign, as well as the multi-wavelength data as a
legacy data repository. We captured M87 in a historically low state, and the core flux dominates over HST-1 at
high energies, making it possible to combine core flux constraints with the more spatially precise very long
baseline interferometry data. We present the most complete simultaneous multi-wavelength spectrum of the active
nucleus to date, and discuss the complexity and caveats of combining data from different spatial scales into one
broadband spectrum. We apply two heuristic, isotropic leptonic single-zone models to provide insight into the
basic source properties, but conclude that a structured jet is necessary to explain M87’s spectrum. We can exclude
that the simultaneous γ-ray emission is produced via inverse Compton emission in the same region producing the
EHT mm-band emission, and further conclude that the γ-rays can only be produced in the inner jets (inward of
HST-1) if there are strongly particle-dominated regions. Direct synchrotron emission from accelerated protons and
secondaries cannot yet be excluded.http://iopscience.iop.org/2041-8205am2022Physic
First sagittarius A* Event Horizon Telescope results. VI. Testing the black hole metric
Galaxie
A universal power-law prescription for variability from synthetic images of black hole accretion flows
Instrumentatio
First sagittarius A* Event Horizon Telescope results. IV. Variability, morphology, and black hole mass
Galaxie
Broadband multi-wavelength properties of M87 during the 2017 Event Horizon Telescope campaign
High Energy AstrophysicsInstrumentatio
A global research priority agenda to advance public health responses to fatty liver disease
Background & aims
An estimated 38% of adults worldwide have non-alcoholic fatty liver disease (NAFLD). From individual impacts to widespread public health and economic consequences, the implications of this disease are profound. This study aimed to develop an aligned, prioritised fatty liver disease research agenda for the global health community.
Methods
Nine co-chairs drafted initial research priorities, subsequently reviewed by 40 core authors and debated during a three-day in-person meeting. Following a Delphi methodology, over two rounds, a large panel (R1 n = 344, R2 n = 288) reviewed the priorities, via Qualtrics XM, indicating agreement using a four-point Likert-scale and providing written feedback. The core group revised the draft priorities between rounds. In R2, panellists also ranked the priorities within six domains: epidemiology, models of care, treatment and care, education and awareness, patient and community perspectives, and leadership and public health policy.
Results
The consensus-built fatty liver disease research agenda encompasses 28 priorities. The mean percentage of ‘agree’ responses increased from 78.3 in R1 to 81.1 in R2. Five priorities received unanimous combined agreement (‘agree’ + ‘somewhat agree’); the remaining 23 priorities had >90% combined agreement. While all but one of the priorities exhibited at least a super-majority of agreement (>66.7% ‘agree’), 13 priorities had 90% combined agreement.
Conclusions
Adopting this multidisciplinary consensus-built research priorities agenda can deliver a step-change in addressing fatty liver disease, mitigating against its individual and societal harms and proactively altering its natural history through prevention, identification, treatment, and care. This agenda should catalyse the global health community’s efforts to advance and accelerate responses to this widespread and fast-growing public health threat.
Impact and implications
An estimated 38% of adults and 13% of children and adolescents worldwide have fatty liver disease, making it the most prevalent liver disease in history. Despite substantial scientific progress in the past three decades, the burden continues to grow, with an urgent need to advance understanding of how to prevent, manage, and treat the disease. Through a global consensus process, a multidisciplinary group agreed on 28 research priorities covering a broad range of themes, from disease burden, treatment, and health system responses to awareness and policy. The findings have relevance for clinical and non-clinical researchers as well as funders working on fatty liver disease and non-communicable diseases more broadly, setting out a prioritised, ranked research agenda for turning the tide on this fast-growing public health threat
Whole-genome sequencing reveals host factors underlying critical COVID-19
Critical COVID-19 is caused by immune-mediated inflammatory lung injury. Host genetic variation influences the development of illness requiring critical care1 or hospitalization2,3,4 after infection with SARS-CoV-2. The GenOMICC (Genetics of Mortality in Critical Care) study enables the comparison of genomes from individuals who are critically ill with those of population controls to find underlying disease mechanisms. Here we use whole-genome sequencing in 7,491 critically ill individuals compared with 48,400 controls to discover and replicate 23 independent variants that significantly predispose to critical COVID-19. We identify 16 new independent associations, including variants within genes that are involved in interferon signalling (IL10RB and PLSCR1), leucocyte differentiation (BCL11A) and blood-type antigen secretor status (FUT2). Using transcriptome-wide association and colocalization to infer the effect of gene expression on disease severity, we find evidence that implicates multiple genes—including reduced expression of a membrane flippase (ATP11A), and increased expression of a mucin (MUC1)—in critical disease. Mendelian randomization provides evidence in support of causal roles for myeloid cell adhesion molecules (SELE, ICAM5 and CD209) and the coagulation factor F8, all of which are potentially druggable targets. Our results are broadly consistent with a multi-component model of COVID-19 pathophysiology, in which at least two distinct mechanisms can predispose to life-threatening disease: failure to control viral replication; or an enhanced tendency towards pulmonary inflammation and intravascular coagulation. We show that comparison between cases of critical illness and population controls is highly efficient for the detection of therapeutically relevant mechanisms of disease
- …